Alzheimer's Disease: From Immune Homeostasis to Neuroinflammatory Condition

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Nov 11

PMID 36361799

Authors

Lucia Princiotta Cariddi

Marco Mauri

Marco Cosentino

Maurizio Versino

Franca Marino

Affiliations

Soon will be listed here.

Abstract

Alzheimer's Disease is the most common cause in the world of progressive cognitive decline. Although many modifiable and non-modifiable risk factors have been proposed, in recent years, neuroinflammation has been hypothesized to be an important contributing factor of Alzheimer's Disease pathogenesis. Neuroinflammation can occur through the combined action of the Central Nervous System resident immune cells and adaptive peripheral immune system. In the past years, immunotherapies for neurodegenerative diseases have focused wrongly on targeting protein aggregates Aβ plaques and NFT treatment. The role of both innate and adaptive immune cells has not been fully clarified, but several data suggest that immune system dysregulation plays a key role in neuroinflammation. Recent studies have focused especially on the role of the adaptive immune system and have shown that inflammatory markers are characterized by increased CD4+ Teff cells' activities and reduced circulating CD4+ Treg cells. In this review, we discuss the key role of both innate and adaptive immune systems in the degeneration and regeneration mechanisms in the pathogenesis of Alzheimer's Disease, with a focus on how the crosstalk between these two systems is able to sustain brain homeostasis or shift it to a neurodegenerative condition.

Citing Articles

The study on cuproptosis in Alzheimer's disease based on the cuproptosis key gene .

Chen G, Xi E, Gu X, Wang H, Tang Q Front Aging Neurosci. 2025; 16:1480332.

PMID: 39759399 PMC: 11696982. DOI: 10.3389/fnagi.2024.1480332.

A subcellular sampling instrument allows spatial resolution of amyloid deposit-derived organelle-specific effects in microglia.

Slotos R, Nguyen T, Fiska L, Friedland K, Endres K Commun Biol. 2025; 8(1):3.

PMID: 39753747 PMC: 11699115. DOI: 10.1038/s42003-024-07405-w.

Risk Factors and Diagnostic Model Construction of Chronic Pain with Cognitive Impairment.

Zhang C, Su Y, Zeng X, Zhu X, Gao R, Liu W J Pain Res. 2024; 17:4331-4342.

PMID: 39712461 PMC: 11662672. DOI: 10.2147/JPR.S485000.

Bifurcations in coupled amyloid-β aggregation-inflammation systems.

Chakrabarti K, Bakhtiari D, Rezaei-Ghaleh N NPJ Syst Biol Appl. 2024; 10(1):80.

PMID: 39080352 PMC: 11289389. DOI: 10.1038/s41540-024-00408-7.

Comprehensive analysis of genetic risk loci uncovers novel candidate genes and pathways in the comorbidity between depression and Alzheimer's disease.

Hofstra B, Kas M, Verbeek D Transl Psychiatry. 2024; 14(1):253.

PMID: 38862462 PMC: 11166962. DOI: 10.1038/s41398-024-02968-y.

References

Chen Z, Palmer T . Cellular repair of CNS disorders: an immunological perspective. Hum Mol Genet. 2008; 17(R1):R84-92. DOI: 10.1093/hmg/ddn104. View

Mietelska-Porowska A, Wojda U . T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers. J Immunol Res. 2017; 2017:4626540. PMC: 5331319. DOI: 10.1155/2017/4626540. View

Marsh S, Abud E, Lakatos A, Karimzadeh A, Yeung S, Davtyan H . The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function. Proc Natl Acad Sci U S A. 2016; 113(9):E1316-25. PMC: 4780638. DOI: 10.1073/pnas.1525466113. View

Banerjee R, Mosley R, Reynolds A, Dhar A, Jackson-Lewis V, Gordon P . Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PLoS One. 2008; 3(7):e2740. PMC: 2481277. DOI: 10.1371/journal.pone.0002740. View

van Zwam M, Huizinga R, Heijmans N, van Meurs M, Wierenga-Wolf A, Melief M . Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis. J Pathol. 2008; 217(4):543-51. DOI: 10.1002/path.2476. View

Hedrick S . Thymus lineage commitment: a single switch. Immunity. 2008; 28(3):297-9. DOI: 10.1016/j.immuni.2008.02.011. View

Oberstein T, Taha L, Spitzer P, Hellstern J, Herrmann M, Kornhuber J . Imbalance of Circulating T17 and Regulatory T Cells in Alzheimer's Disease: A Case Control Study. Front Immunol. 2018; 9:1213. PMC: 5994416. DOI: 10.3389/fimmu.2018.01213. View

Yao P, Lin P, Gokoolparsadh A, Assareh A, Thang M, Voineagu I . Coexpression networks identify brain region-specific enhancer RNAs in the human brain. Nat Neurosci. 2015; 18(8):1168-74. DOI: 10.1038/nn.4063. View

Ardura-Fabregat A, Boddeke E, Boza-Serrano A, Brioschi S, Castro-Gomez S, Ceyzeriat K . Targeting Neuroinflammation to Treat Alzheimer's Disease. CNS Drugs. 2017; 31(12):1057-1082. PMC: 5747579. DOI: 10.1007/s40263-017-0483-3. View

10.

Tang Y, Le W . Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol Neurobiol. 2015; 53(2):1181-1194. DOI: 10.1007/s12035-014-9070-5. View

11.

Planas A, Chamorro A . Regulatory T cells protect the brain after stroke. Nat Med. 2009; 15(2):138-9. DOI: 10.1038/nm0209-138. View

12.

Itagaki S, McGeer P, Akiyama H . Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue. Neurosci Lett. 1988; 91(3):259-64. DOI: 10.1016/0304-3940(88)90690-8. View

13.

Appel S . CD4+ T cells mediate cytotoxicity in neurodegenerative diseases. J Clin Invest. 2008; 119(1):13-5. PMC: 2613473. DOI: 10.1172/JCI38096. View

14.

Gandolfo M, Jang H, Bagnasco S, Ko G, Agreda P, Satpute S . Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int. 2009; 76(7):717-29. DOI: 10.1038/ki.2009.259. View

15.

Dawson T, Golde T, Lagier-Tourenne C . Animal models of neurodegenerative diseases. Nat Neurosci. 2018; 21(10):1370-1379. PMC: 6615039. DOI: 10.1038/s41593-018-0236-8. View

16.

Mumtaz S, Rana J, Choi E, Han I . Microwave Radiation and the Brain: Mechanisms, Current Status, and Future Prospects. Int J Mol Sci. 2022; 23(16). PMC: 9409438. DOI: 10.3390/ijms23169288. View

17.

Cras P, Kawai M, Lowery D, Greenberg B, Perry G . Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci U S A. 1991; 88(17):7552-6. PMC: 52339. DOI: 10.1073/pnas.88.17.7552. View

18.

Machhi J, Kevadiya B, Muhammad I, Herskovitz J, Olson K, Mosley R . Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders. Mol Neurodegener. 2020; 15(1):32. PMC: 7275301. DOI: 10.1186/s13024-020-00375-7. View

19.

Louveau A, Harris T, Kipnis J . Revisiting the Mechanisms of CNS Immune Privilege. Trends Immunol. 2015; 36(10):569-577. PMC: 4593064. DOI: 10.1016/j.it.2015.08.006. View

20.

Ceyzeriat K, Zilli T, Millet P, Frisoni G, Garibotto V, Tournier B . Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer's Disease. Curr Alzheimer Res. 2020; 17(2):112-125. DOI: 10.2174/1567205017666200304085513. View